The Structural Disease Center

Filter Your Results

 

News

 

Gore REDUCE Trial Evaluates Cardioform Device for PFO Closure

September 19, 2017 -- Lars Søndergaard, MD, et al published the findings from the Gore REDUCE Trial in The New England Journal of Medicine (NEJM;2017;377:1033 -- 1042).…

Carag Begins European Marketing After CE Mark Approval for Bioresorbable Septal Occluder  

September 18, 2017 -- Carag AG announced that it has received European CE Mark approval for its Carag bioresorbable septal occluder (CBSO), allowing Carag to fully market the …

Findings Published From CLOSE Trial of PFO Closure After Stroke

September 19, 2017 -- Principal Investigator Jean-Louis Mas, MD, et al published findings from the CLOSE trial in The New England Journal of Medicine (NEJM; 2017;377:1011 -- 1…

First Clinical Tricuspid Bicuspidization Procedure Completed Using Micro Interventional Devices’ MIA Technology

September 7, 2017 -- Micro Interventional Devices, Inc. (MID) has completed a first-in-human tricuspid valve bicuspidization procedure using the company's minimally invasi…

United States Pivotal Study Begins for Abbott's Amplatzer Device to Treat Patent Ductus Arteriosus in Newborns

August 30, 2017 -- Abbott Vascular announced that it has initiated a United States pivotal clinical study evaluating the safety and effectiveness of a modified version of its …

IDE Study Begins for BioVentrix's Revivent TC System for Ischemic Cardiomyopathy

August 21, 2017 -- BioVentrix, Inc. announced enrollment of the first patient in the international arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrat…

Postapproval Study Evaluates Amplatzer Septal Occluder for Closure of Secundum ASD

August 14, 2017 -- Findings from a multicenter, prospective postapproval study of percutaneous closure of secundum atrial septal defects (ASDs) with the Amplatzer septal occlu…

Emerging Options for Anticoagulation in LAA Closure

Jessica Tilton, PharmD, BCACP; John Shilka, PharmD; Adhir Shroff, MD, MPH; and Vicki Groo, PharmD

July/August 2017—Managing anticoagulation and antiplatelet therapy in patients undergoing percutaneous left atrial appendage closure with the Watchman device.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.